Copyright
©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2034-2056
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2034
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2034
Patient characteristics | Value |
Age, median (range, yr) | 42.0 (6-87) |
Gender, male/female/NA | 37/44/1 |
Comorbidities | |
Hypertension | 22 |
Diabetes | 15 |
Dyslipidemia | 4 |
Heart disease | 3 |
Cerebrovascular | 0 |
Respiratory disease | 4 |
Renal dysfunction | 5 |
Obesity | 16 |
Pregnancy | 2 |
Malignancy | 2 |
History of abdominal surgery | 13 |
Others | 10 |
Alcohol consumption, none/low/heavy/NA | 53/9/0/20 |
History of smoking, never/experience/current/NA | 32/2/0/48 |
Severity of COVID-19 | |
Non-severe/severe/critical/NA | 35/23/20/4 |
Symptoms | |
Fever | 49 |
Breath shortness | 16 |
Cough | 28 |
Dyspnea | 18 |
Sore throat | 18 |
Fatigue | 9 |
Headache | 7 |
Myalgia | 10 |
Anorexia | 13 |
Diarrhea | 16 |
Abdominal pain | 75 |
Nausea | 39 |
Vomiting | 48 |
Others | 23 |
Blood test | |
WBC, median (range, × 103/mm3) | 13.10 (3.40-230.00) |
PLT, median (range, × 103/mm3) | 235.5 (52.0-502.0) |
D-Dimer, median (range, μg/mL) | 4.9 (0.3-17.7) |
Amylase, median (range, U/L) | 635 (47-4530) |
Lipase, median (range, U/L) | 895.5 (35.6-11920.0) |
LDH, median (range, U/L) | 366.0 (170-3553) |
CRP, median (range, mg/dL) | 8.5 (0.3-59.7) |
Imaging findings (n = 75) | |
Pancreatic enlargement | 42 |
Peripancreatic fluid collection | 33 |
Peripancreatic inflammatory change | 48 |
Pancreatic ischemic change | 12 |
No change of pancreas | 6 |
Not visualized | 2 |
Severity of acute pancreatitis | |
Mild/moderate/severe/NA | 28/20/28/6 |
Therapy for COVID-19 | |
Lopinavir/ritonavir | 4 |
Favipiravir | 4 |
Umifenovir | 2 |
Remdesivir | 8 |
Hydroxychloroquine | 2 |
Tocilizumab | 2 |
Corticosteroid (n = 53) | 21 |
Oxygen therapy (n = 69) | 42 |
Mechanical ventilation | 19 |
Therapy for acute pancreatitis | |
Conservative therapy/surgical drainage/NA | 72/4/6 |
Period of hospitalization, median (range, day) | 7.5 (2-76) |
Prognosis | |
Alive/death/NA | 69/10/3 |
Case No. | Ref. | Age | Gender | Diagnostic evidence for SARS-CoV-2 | Severity of COVID-19 | Abdominal pain | Amylase/lipase (IU/L) | Abdominal image findings | Modality of image | Severity of acute pancreatitis | Treatment for pancreatitis | Prognosis |
1 | Anand et al[70] | 59 | Female | RT-PCR | Non-severe | Presence | NA/NA | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
2 | Hadi et al[71] | 47 | Female | RT-PCR | Critical | Absence | 1500/NA | Diffuse pancreatic enlargement | AUS | Severe | NA | NA |
3 | Hadi et al[71] | 68 | Female | RT-PCR | Critical | Presence | 934/NA | NA | NA | Severe | NA | NA |
4 | Aloysius et al[72] | 36 | Female | RT-PCR | Critical | Presence | 325/627 | No change | CT | Severe | Conservative | Alive |
5 | Miao et al[73] | 26 | Female | RT-PCR | Non-severe | Presence | NA/430 | Diffuse pancreatic enlargement | CT | NA | NA | Alive |
6 | Szatmary et al[74] | 29 | Male | RT-PCR | Non-severe | Presence | 77/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
7 | Szatmary et al[74] | 47 | Male | RT-PCR | Non-severe | Presence | 211/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
8 | Rabice et al[75] | 36 | Female | RT-PCR | Severe | Presence | 88/875 | Not visualized | AUS | Mild | Conservative | Alive |
9 | Alloway et al[76] | 7 | Female | RT-PCR | Non-severe | Presence | NA/1672 | Diffuse pancreatic enlargement | AUS and CT | Mild | Conservative | Alive |
10 | Karimzadeh et al[77] | 65 | Female | RT-PCR | Severe | Presence | 285/294 | No change | CT | Mild | Conservative | Alive |
11 | Gonzalo-Voltas et al[78] | 76 | Male | RT-PCR | Non-severe | Presence | 3568/NA | Diffuse pancreatic enlargement | CT | Moderate | Conservative | Alive |
12 | Bokhari et al[79] | 32 | Male | RT-PCR | Non-severe | Presence | 672/721 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
13 | Mazrouei et al[80] | 24 | Male | RT-PCR | Non-severe | Presence | 391/578 | Enlargement of pancreatic tail, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
14 | Ahmed et al[81] | 47 | Male | RT-PCR | Severe | Presence | 349/NA | Peripancreatic inflammatory change | CT | Severe | NA | Alive |
15 | Brikman et al[82] | 61 | Male | RT-PCR | Severe | Presence | 142/203 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
16 | Kataria et al[83] | 49 | Female | RT-PCR | Severe | Presence | 501/1541 | Diffuse pancreatic enlargement, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
17 | Cerda-Contreras et al[84] | 72 | Female | RT-PCR | Severe | Absence | 1789/1247 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Severe | Conservative | Dead |
18 | Cheung et al[85] | 38 | Male | RT-PCR | Non-severe | Presence | NA/338.7 | Acute pancreatitis | CT | NA | Conservative | Alive |
19 | Kumaran et al[86] | 67 | Female | RT-PCR | Severe | Presence | 1483/NA | Peripancreatic inflammatory change and fluid collection, non-enhancement of most of the head and proximal body | CT | Severe | Conservative | Alive |
20 | Purayil et al[87] | 58 | Male | RT-PCR | Non-severe | Presence | 249/NA | Not visualized | AUS | Mild | Conservative | Alive |
21 | Dietrich et al[88] | 72 | Male | RT-PCR | Critical | Presence | NA/185 | Normal pancreas | CT | Mild | NA | Alive |
22 | Patnaik et al[89] | 29 | Male | RT-PCR | Non-severe | Presence | 2861/1650 | Diffuse pancreatic enlargement, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
23 | Wang et al[90] | 42 | Male | RT-PCR | Critical | Presence | 132/382 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Dead |
24 | Wang et al[90] | 35 | Male | RT-PCR | Non-severe | Presence | NA/1042 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
25 | Alves et al[91] | 56 | Female | RT-PCR | Critical | Presence | 544/2993 | Dffuse pancreatic enlargement, peripancreatic inflammatory change | CT and MRI | Severe | Conservative | Alive |
26 | Kurihara et al[92] | 55 | Male | RT-PCR | Critical | Absence | 252/263 | Pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
27 | Lakshmanan and Malik[93] | 68 | Male | RT-PCR | Non-severe | Absence | 1030/2035 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
28 | Samies et al[94] | 15 | Male | RT-PCR | Non-severe | Presence | NA/233 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
29 | Samies et al[94] | 11 | Male | RT-PCR | Non-severe | Presence | 215/953 | No change | CT | Mild | Conservative | Alive |
30 | Samies et al[94] | 16 | Female | RT-PCR | Non-severe | Presence | NA/1909 | Pancreatic enlargement | CT | Mild | Conservative | Alive |
31 | Fernandes et al[95] | 36 | Female | RT-PCR | NA | Presence | 710/640 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
32 | Stevens et al[55] | 10 | Female | Serological IgG | Severe | Presence | NA/1371 | Peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
33 | Shinohara et al[96] | 58 | Male | RT-PCR | Critical | Presence | 795/NA | Diffuse pancreatic enlargement peripancreatic inflammatory change | CT | Moderate | Conservative | Alive |
34 | Meyers et al[97] | 67 | Male | RT-PCR | NA | Presence | NA/5295 | Interstitial edematous pancreatitis peripancreatic inflammatory change | CT | Moderate | NA | NA |
35 | Ghosh et al[98] | 63 | Male | RT-PCR | Severe | Absence | 58/412 | Focal pancreatic enlargement, peripancreatic fluid collection | CT | NA | Conservative | Alive |
36 | Tollard et al[99] | 32 | Female | RT-PCR | Critical | Presence | NA/321 | Diffuse pancreatic enlargement peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
37 | Kandasamy et al[100] | 45 | Female | RT-PCR | Severe | Presence | 364/293 | Diffuse pancreatic enlargement, peripancreatic inflammatory change and fluid collection | CT | Moderate | Conservative | Alive |
38 | Hassani et al[101] | 78 | Female | RT-PCR | Critical | Presence | 1200/1450 | Pancreatic enlargement necrotizing pancreatitis | AUS and CT | Severe | Conservative | Dead |
39 | Suchman et al[56] | 10 | Female | RT-PCR | Non-severe | Presence | NA/365.7 | NA | NA | Moderate | Conservative | Alive |
40 | Suchman et al[56] | 16 | Male | RT-PCR | Critical | Presence | NA/233.3 | NA | NA | Severe | Conservative | Alive |
41 | Narang et al[102] | 20 | Female | RT-PCR | Severe | Presence | 1168/916 | Acute pancreatitis | MRI | Severe | Conservative | Alive |
42 | Acherjya et al[103] | 57 | Female | RT-PCR | Severe | Presence | 80/8352 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Moderate | Conservative | Alive |
43 | Alwaeli et al[104] | 30 | Male | RT-PCR | Critical | Presence | 151/1022 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
44 | Simou et al[105] | 67 | NA | RT-PCR | Severe | Absence | NA/576 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
45 | Jespersen Nizamic et al[106] | 49 | Female | RT-PCR | Non-severe | Presence | NA/2864 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
46 | Abraham et al[107] | 61 | Female | RT-PCR | Non-severe | Presence | NA/1018 | NA | NA | Mild | Conservative | Alive |
47 | Abhinay et al[108] | 13 | Female | RT-PCR | NA | Presence | 217/365 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
48 | Bouali et al[109] | 60 | Female | RT-PCR | Critical | Presence | NA/627 | Peripancreatic fluid collection | CT | Severe | Drainage of abdominal cavity, total gasterectomy | Dead |
49 | Alharmi et al[110] | 52 | Female | RT-PCR | Non-severe | Presence | 47/NA | Atrophic pancreas, peripancreatic inflammatory change, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
50 | Abbas et al[57] | 13 | Female | RT-PCR | Critical | Presence | 217.8/NA | Fluid collection | CT | Severe | Conservative | Alive |
51 | Bineshfar et al[111] | 14 | Male | RT-PCR | Non-severe | Presence | 1914/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
52 | Paz et al[112] | 14 | Male | RT-PCR | Non-severe | Presence | 196/247 | Peripancreatic inflammatory change, fluid collection | MRI | Mild | Conservative | Alive |
53 | Wifi et al[113] | 72 | Female | RT-PCR | Non-severe | Presence | 1667/710 | No change | CT | Mild | Conservative | Alive |
54 | Sandhu et al[114] | 25 | Female | RT-PCR | Critical | Presence | 350/35.6 | Diffuse pancreatic enlargement | CT | Severe | Conservative | Dead |
55 | Mohammadi Arbati et al[115] | 28 | Male | RT-PCR | Critical | Presence | 1273/758 | Peripancreatic inflammatory change, fluid collection, acute necrotic pancreatitis | CT | Severe | Conservative | Alive |
56 | Amé et al[116] | 42 | Female | RT-PCR | NA | Presence | 2263/2799 | Pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | NA | Conservative | Alive |
57 | Gupta et al[117] | 25 | Female | RT-PCR | Severe | Presence | 1814/11920 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Severe | Conservative | Alive |
58 | Muhammad Abrar Jeelani et al[118] | 24 | Male | RT-PCR | Non-severe | Presence | NA/4174 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
59 | Maalouf et al[119] | 62 | Male | RT-PCR | Non-severe | Presence | NA/4361 | Peripancreatic inflammatory change, necrotic collection | MRI | Moderate | Conservative | Alive |
60 | Sanchez et al[120] | 16 | Male | RT-PCR | Severe | Presence | NA/961 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
61 | Ehsan et al[121] | 13 | Female | RT-PCR | Severe | Presence | 598/2331 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
62 | Hanif et al[122] | 30 | Female | RT-PCR | Severe | Presence | 820/626 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
63 | Chandra et al[123] | 53 | Male | RT-PCR | Critical | Presence | NA/1200 | Peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
64 | Alfishawy et al[124] | 17 | Male | RT-PCR | Severe | Absence | 285/273 | Pancreatic loculations | CT | Moderate | Conservative | Alive |
65 | Berrichi et al[125] | 36 | Female | RT-PCR | Critical | Presence | NA/2570 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
66 | Berrichi et al[125] | 51 | Female | RT-PCR | Severe | Presence | NA/676 | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
67 | Kripalani et al[126] | 79 | Female | RT-PCR | Critical | Presence | 1075/6178 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, acute necrotic pancreatitis | CT | Severe | Cycto-jejunostomy | Alive |
68 | Narayan et al[127] | 28 | Male | RT-PCR | Critical | Presence | Elevated/elevated | Diffuse pancreatic enlargement, peripancreatic inflammatory change and acute necrotic pancreatitis | CT | Severe | Conservative | Dead |
69 | Narayan et al[127] | 45 | Female | RT-PCR | Severe | Presence | Elevated/elevated | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
70 | Eldaly et al[128] | 44 | Male | RT-PCR | Non-severe | Presence | 773/286 | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
71 | Basukala et al[129] | 49 | Female | RT-PCR | Non-severe | Presence | 1563/568 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | CT | Severe | Gastrocolic ligament and followed by necrotic debridement, and drainage placement | Dead |
72 | Schembri Higgans et al[130] | 63 | Female | RT-PCR | Non-severe | Presence | 1079/NA | After Whipple surgery | CT | Mild | Conservative | Alive |
73 | Schembri Higgans et al[130] | 87 | Female | RT-PCR | Non-severe | Presence | 499/NA | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
74 | Schembri Higgans et al[130] | 64 | Female | RT-PCR | Non-severe | Presence | 2141/NA | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
75 | Kopiczko et al[131] | 6 | Female | RT-PCR | Non-severe | Presence | 1124/4250 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
76 | Kareva et al[58] | 11 | Male | Serological IgG | Non-severe | Presence | 489/576 | Edematous appendix no change of pancreas | AUS | NA | Conservative | Alive |
77 | da Costa Ferreira et al[132] | 35 | Male | RT-PCR | Severe | Presence | 1669/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection normal gallbladder and biliary tract | CT | Severe | Conservative | Alive |
78 | Sánchez-Gollarte et al[133] | 60 | Male | Serological IgG | Severe | Presence | 4530/2220 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | CT | Severe | Drainage of abdominal cavity | Alive |
79 | Sudarsanam et al[134] | 35 | Male | RT-PCR | Non-severe | Presence | Normal/normal | Peripancreatic inflammatory change, fluid collection, necrotic pancreatitis of tail | CT | NA | Conservative | Alive |
80 | Faghih Dinevari et al[135] | 18 | Female | RT-PCR | Non-severe | Presence | 1288/1541 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
81 | Goldstein et al[136] | 11 | Male | Serological IgG | Severe | Presence | 1607/2434 | Peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | MRI | Moderate | Conservative | Alive |
82 | Gadiparthi et al[137] | 74 | Female | RT-PCR | Non-severe | Presence | 229/7550 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
Case No. | Alcohol | Biliary | Hypertrig | Drug | Acute aggravati | Hypercal | Infection | Ischemia/reperfusi | Trauma/ anatomy | Genetics | MIS-C/PIMS |
1 | N | ? | ? | Y | N | ? | ? | N | N | - | - |
2 | N | N1 | N | ? | N | N | ? | Y | N | - | - |
3 | ? | ? | N | ? | N | N | ? | Y | N | - | - |
4 | N | N | N | N | N | ? | ? | N | N | - | - |
5 | N | N | N | N | N | N | N2 | N | N | - | - |
6 | N | N | N | N | N | ? | ? | ? | N | - | - |
7 | N | N | N | N | N | ? | ? | ? | N | - | - |
8 | N | N | N | N | N | ? | ? | N | N | - | - |
9 | N | ? | ? | N | N | ? | ? | N | N | ? | N |
10 | ? | N | N | N | N | N | ? | N | N | - | - |
11 | N | N | ? | Y | N | ? | ? | N | N | - | - |
12 | N | N | N | N | N | N | ? | N | N | - | - |
13 | N | N | ? | N | N | ? | ? | N | N | - | - |
14 | ? | Y | ? | Y | N | ? | ? | N | N | - | - |
15 | N | N | N | Y | N | N | ? | N | N | - | - |
16 | N | N | N | Y | N | N | ? | N | N | - | - |
17 | ? | ? | N | Y | N | N | ? | Y | N | - | - |
18 | N | N | N | N | N | N | ? | N | N | - | - |
19 | N | N | N | N | N | N | ? | N | N | - | - |
20 | N | N | ? | N | N | ? | ? | N | N | - | - |
21 | N | N | ? | N | N | ? | ? | N | N | - | - |
22 | N | N | N | N | N | N | ? | N | N | - | - |
23 | N | N | N | N | N | N | ? | N | N | - | - |
24 | N | N | N | N | N | N | ? | N | N | - | - |
25 | N | N | N | N | N | N | ? | N | N | - | - |
26 | ? | N | N | Y | N | N | ? | Y | N | - | - |
27 | N | N | N | N | N | N | ? | N | N | - | - |
28 | N | ? | N | N | N | ? | ? | N | N | N | N |
29 | N | N | N | N | N | ? | ? | N | N | N | ? |
30 | N | Y | N | N | Y | ? | ? | N | N | N | N |
31 | N | N1 | ? | N | N | ? | ? | N | N | - | - |
32 | N | Y | N | N | N | ? | ? | N | N | ? | Y |
33 | N | N | N | Y | N | N | ? | Y | N | - | - |
34 | N | N | N | N | N | ? | ? | N | N | - | - |
35 | N | ? | ? | ? | N | ? | ? | N | N | - | - |
36 | N | Y | N | N | N | N | ? | Y | N | - | - |
37 | N | N | ? | N | N | ? | ? | N | N | - | - |
38 | N | N | N | N | N | N | ? | N | N | - | - |
39 | N | ? | ? | ? | N | ? | ? | ? | ? | ? | Y |
40 | N | ? | ? | ? | N | ? | ? | ? | ? | ? | N |
41 | N | N | N | Y | N | ? | ? | Y | N | - | - |
42 | N | N | N | Y | N | N | ? | N | N | - | - |
43 | N | N | N | N | N | N | N2 | N | N | - | - |
44 | N | N | N | Y | N | N | N2 | Y | N | - | - |
45 | N | ? | ? | N | N | ? | ? | N | N | - | - |
46 | ? | ? | ? | N | N | N | ? | N | N | - | - |
47 | ? | ? | ? | N | N | ? | ? | N | N | ? | N |
48 | ? | ? | ? | N | N | ? | ? | N | N | - | - |
49 | N | N | N | Y | N | N | ? | N | N | - | - |
50 | N | N | N | Y | N | ? | N2 | N | N | N | Y |
51 | N | N | ? | N | N | ? | ? | N | N | ? | N |
52 | ? | N | N | N | N | ? | ? | N | N | N | N |
53 | ? | N | N | N | N | N | ? | N | N | - | - |
54 | N | Y | N | N | N | N | ? | N | N | - | - |
55 | N | N | N | N | N | N | ? | N | N | - | - |
56 | N | N | N | N | N | N | ? | N | N | - | - |
57 | N | N | N | ? | N | N | ? | N | N | - | - |
58 | N | N | N | N | N | N | ? | N | N | - | - |
59 | N | N | N | N | N | ? | ? | N | N | - | - |
60 | N | N | ? | N | N | N | ? | N | N | N | N |
61 | N | N | N | N | N | ? | ? | N | N | ? | ? |
62 | N | ? | N | Y | N | N | N | Y | N | - | - |
63 | N | N | N | N | N | ? | ? | N | N | - | - |
64 | N | Y | Y | N | N | ? | ? | N | N | ? | ? |
65 | ? | N | ? | N | N | ? | ? | N | N | - | - |
66 | ? | N | ? | N | N | ? | ? | N | N | - | - |
67 | N | N | ? | N | N | ? | ? | N | N | - | - |
68 | ? | N | N | Y | N | ? | ? | N | N | - | - |
69 | ? | ? | ? | Y | N | ? | ? | Y | N | - | - |
70 | N | N | N | N | N | ? | ? | N | N | - | - |
71 | N | N | N | N | N | N | ? | N | N | - | - |
72 | N | N | ? | N | N | ? | ? | N | Y | - | - |
73 | ? | N | N | N | N | ? | ? | N | N | - | - |
74 | ? | Y | ? | N | N | ? | ? | N | N | - | - |
75 | N | N | N | N | N | N | N | N | N | ? | N |
76 | N | N | ? | N | N | N | ? | N | N | ? | Y |
77 | N | Y | N | N | N | N | ? | N | N | - | - |
78 | ? | N | ? | ? | N | N | ? | N | N | - | - |
79 | N | N | N | N | N | N | ? | N | N | - | - |
80 | N | N | N | N | N | N | ? | N | N | N | N |
81 | ? | ? | ? | Y | N | ? | N2 | N | N | ? | Y |
82 | N | N | N | N | N | N | ? | N | N | - | - |
- Citation: Onoyama T, Koda H, Hamamoto W, Kawahara S, Sakamoto Y, Yamashita T, Kurumi H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Review on acute pancreatitis attributed to COVID-19 infection. World J Gastroenterol 2022; 28(19): 2034-2056
- URL: https://www.wjgnet.com/1007-9327/full/v28/i19/2034.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i19.2034